Clinical significance of nuclear DNA content in pancreatic carcinoma

Publisher Website
Google Scholar
Abstract
The nuclear DNA content or 62 pancreatic adenocarcinomas was analysed by flow cylometry from paraffinembedded material. Radical surgery could be performed in 12 of the 24 cases with diploid carcinoma, but only in 3 of the 38 cases with a non‐diploid tumour (P=0.0002); the radically resected carcinomas also had a lower fraction of cells in the S‐phase (P=0.009). Non‐diploid nuclear DNA content (38 cases, 61 per cent) was associated with advanced stage (P=0.002), poor histological differentiation (grade II or III, P=0.004), and primary tumour site in the body or the tail as compared with the head (P=0.01). The median survival time of the patients with diploid carcinoma was 13±3 (SE) months, and that of the patients with non‐diploid carcinoma 3±1 months (P=0.0001). The DNA index with the cutoff value 1.4 was a slightly more powerful prognostic factor than DNA ploidy, and it was the most important independent prognostic factor in Cox's multivariate analysis (PP<0.03). We conclude that diploid pancreatic carcinomas are associated with a longer survival than the non‐diploid ones, and that radically operable carcinomas form a special subgroup with frequent diploidy and less aggressive biological behaviour.